Reoux JP - Search Results

1

The Alcohol Use Disorders Identification Test (AUDIT) predicts alcohol withdrawal symptoms during inpatient detoxification.

Reoux JP, Malte CA, Kivlahan DR, Saxon AJ. Reoux JP, et al. J Addict Dis. 2002;21(4):81-91. doi: 10.1300/J069v21n04_08. J Addict Dis. 2002. PMID: 12296504

2

Disulfiram use in patients with abnormal liver function test results.

Saxon AJ, Sloan KL, Reoux J, Haver VM. Saxon AJ, et al. J Clin Psychiatry. 1998 Jun;59(6):313-6. doi: 10.4088/jcp.v59n0607. J Clin Psychiatry. 1998. PMID: 9671344

3

Routine hospital alcohol detoxification practice compared to symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar).

Reoux JP, Miller K. Reoux JP, et al. Am J Addict. 2000 Spring;9(2):135-44. doi: 10.1080/10550490050173208. Am J Addict. 2000. PMID: 10934575

4

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.

Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL. Reoux JP, et al. Alcohol Clin Exp Res. 2001 Sep;25(9):1324-9. Alcohol Clin Exp Res. 2001. PMID: 11584152 Clinical Trial.

5

A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.

Oreskovich MR, Saxon AJ, Ellis ML, Malte CA, Reoux JP, Knox PC. Oreskovich MR, et al. Among authors: reoux jp. Drug Alcohol Depend. 2005 Jan 7;77(1):71-9. doi: 10.1016/j.drugalcdep.2004.07.008. Drug Alcohol Depend. 2005. PMID: 15607843 Clinical Trial.

6

Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal.

Reoux JP, Saxon AJ, Shen D. Reoux JP, et al. J Clin Psychopharmacol. 2006 Feb;26(1):105-7. doi: 10.1097/01.jcp.0000196416.06729.fe. J Clin Psychopharmacol. 2006. PMID: 16415725 Clinical Trial. No abstract available.

7

A comparison of two versions of the clinical institute withdrawal assessment for alcohol: the CIWA-Ar and CIWA-AD.

Reoux JP, Oreskovich MR. Reoux JP, et al. Am J Addict. 2006 Jan-Feb;15(1):85-93. doi: 10.1080/10550490500419136. Am J Addict. 2006. PMID: 16449097

8

Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.

Davison JW, Sweeney ML, Bush KR, Davis Correale TM, Calsyn DA, Reoux JP, Sloan KL, Kivlahan DR. Davison JW, et al. Among authors: reoux jp. J Addict Dis. 2006;25(4):27-35. doi: 10.1300/J069v25n04_03. J Addict Dis. 2006. PMID: 17088223

9

Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial.

Simpson TL, Achtmeyer C, Batten L, Reoux J, Shofer J, Peskind ER, Saxon AJ, Raskind MA. Simpson TL, et al. Alcohol Alcohol. 2024 Jul 21;59(5):agae062. doi: 10.1093/alcalc/agae062. Alcohol Alcohol. 2024. PMID: 39270736 Clinical Trial.

10

Guidelines for the successful psychotherapy of substance abusers.

Kaufman E, Reoux J. Kaufman E, et al. Am J Drug Alcohol Abuse. 1988;14(2):199-209. doi: 10.3109/00952999809001547. Am J Drug Alcohol Abuse. 1988. PMID: 3177339 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters